Organon & Co. (OGN) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is neutral — 3 Buy, 2 Hold, 3 Sell.
The consensus price target is $6.50 (low: $5.00, high: $8.00), representing a downside of 25.3% from the current price $8.70.
Analysts estimate Earnings Per Share (EPS) of $4.11 and revenue of $6.41B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $3.36 vs est $4.11 (missed -18.2%). 2025: actual $0.72 vs est $3.75 (missed -80.8%). Analyst accuracy: 0%.
OGN Stock — 12-Month Price Forecast
$6.50
▼ -25.29% Downside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for Organon & Co., the average price target is $6.50, with a high forecast of $8.00, and a low forecast of $5.00.
The average price target represents a -25.29% change from the last price of $8.70.
Highest Price Target
$8.00
Average Price Target
$6.50
Lowest Price Target
$5.00
OGN Analyst Ratings
Buy
Based on 8 analysts giving stock ratings to Organon & Co. in the past 3 months
EPS Estimates — OGN
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $3.36
vs Est $4.11
▼ 22.3% off
2025
Actual $0.72
vs Est $3.75
▼ 421.4% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — OGN
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $6.403B
vs Est $6.407B
▼ 0.1% off
2025
Actual $6.216B
vs Est $6.224B
▼ 0.1% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
